Search Results - "Khan, Md Abdul Hye"

Refine Results
  1. 1

    Fructose Stimulates Na/H Exchange Activity and Sensitizes the Proximal Tubule to Angiotensin II by Cabral, Pablo D., Hong, Nancy J., Khan, Md. Abdul Hye, Ortiz, Pablo A., Beierwaltes, William H., Imig, John D., Garvin, Jeffrey L.

    Published in Hypertension (Dallas, Tex. 1979) (01-03-2014)
    “…The proximal nephron reabsorbs 60% to 70% of the fluid and sodium and most of the filtered bicarbonate via Na/H exchanger 3. Enhanced proximal nephron…”
    Get full text
    Journal Article
  2. 2

    Orally Active Epoxyeicosatrienoic Acid Analog Attenuates Kidney Injury in Hypertensive Dahl Salt–Sensitive Rat by Hye Khan, Md Abdul, Neckář, Jan, Manthati, Vijay, Errabelli, Ramu, Pavlov, Tengis S, Staruschenko, Alexander, Falck, John R, Imig, John D

    Published in Hypertension (Dallas, Tex. 1979) (01-11-2013)
    “…Salt-sensitive hypertension leads to kidney injury. The Dahl salt–sensitive hypertensive rat (Dahl SS) is a model of salt-sensitive hypertension and…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition by Hye Khan, Md Abdul, Pavlov, Tengis S, Christain, Sarah V, Neckář, Jan, Staruschenko, Alexander, Gauthier, Kathryn M, Capdevila, Jorge H, Falck, John R, Campbell, William B, Imig, John D

    Published in Clinical science (1979) (01-10-2014)
    “…Epoxyeicosatrienoic acids (EETs) contribute to haemodynamics, electrolyte homoeostasis and blood pressure regulation, leading to the concept that EETs can be…”
    Get more information
    Journal Article
  5. 5

    Epoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition by Skibba, Melissa, Hye Khan, Md Abdul, Kolb, Lauren L, Yeboah, Michael M, Falck, John R, Amaradhi, Radhika, Imig, John D

    Published in Frontiers in pharmacology (30-06-2017)
    “…Renal fibrosis, which is a critical pathophysiological event in chronic kidney diseases, is associated with renal epithelial-to-mesenchymal transition (EMT)…”
    Get full text
    Journal Article
  6. 6

    Epoxyeicosatrienoic Acid Analog EET-A Blunts Development of Lupus Nephritis in Mice by Hye Khan, Md Abdul, Stavniichuk, Anna, Sattar, Mohammad Abdul, Falck, John R, Imig, John D

    Published in Frontiers in pharmacology (10-05-2019)
    “…Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disorder that causes life threatening renal disease and current therapies are limited…”
    Get full text
    Journal Article
  7. 7

    Novel Omega-3 Fatty Acid Epoxygenase Metabolite Reduces Kidney Fibrosis by Sharma, Amit, Hye Khan, Md Abdul, Levick, Scott P, Lee, Kin Sing Stephen, Hammock, Bruce D, Imig, John D

    “…Cytochrome P450 (CYP) monooxygenases epoxidize the omega-3 polyunsaturated fatty acid (PUFA) docosahexaenoic acid into novel epoxydocosapentaenoic acids (EDPs)…”
    Get full text
    Journal Article
  8. 8

    Azilsartan Decreases Renal and Cardiovascular Injury in the Spontaneously Hypertensive Obese Rat by Khan, Md. Abdul Hye, Neckář, Jan, Cummens, Breana, Wahl, Geneva M., Imig, John D.

    Published in Cardiovascular drugs and therapy (01-08-2014)
    “…Purpose Angiotensin II type 1 receptor blockers (ARBs) are widely used in treating hypertension. In the present study, we tested the hypothesis that a novel…”
    Get full text
    Journal Article
  9. 9

    Azilsartan Improves Glycemic Status and Reduces Kidney Damage in Zucker Diabetic Fatty Rats by Khan, Md. Abdul Hye, Neckář, Jan, Haines, Jasmine, Imig, John D.

    Published in American journal of hypertension (01-08-2014)
    “…BACKGROUND Azilsartan medoxomil (AZL-M), an angiotensin II receptor blocker, demonstrates antihypertensive and organ protective effects in hypertension. We…”
    Get full text
    Journal Article
  10. 10

    Radiation-induced afferent arteriolar endothelial-dependent dysfunction involves decreased epoxygenase metabolites by Imig, John D, Hye Khan, Md Abdul, Sharma, Amit, Fish, Brian L, Mandel, Neil S, Cohen, Eric P

    “…Chronic kidney disease is a known complication of hematopoietic stem cell transplant (HSCT) and can be caused by irradiation at the time of the HSCT. In our…”
    Get more information
    Journal Article
  11. 11

    Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury by Khan, Abdul Hye, Falck, John R, Manthati, Vijaya L, Campbell, William B, Imig, John D

    Published in Frontiers in pharmacology (23-09-2014)
    “…Epoxyeicosatrienoic acids (EETs) contribute to blood pressure regulation leading to the concept that EETs can be therapeutically targeted for hypertension and…”
    Get full text
    Journal Article
  12. 12

    A dual farnesoid X receptor/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in mice by Hye Khan, Md. Abdul, Schmidt, Jurema, Stavniichuk, Anna, Imig, John D., Merk, Daniel

    Published in Biochemical pharmacology (01-08-2019)
    “…[Display omitted] Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are the most prevalent metabolic liver disorders and a…”
    Get full text
    Journal Article
  13. 13

    A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes by Hye Khan, Md Abdul, Kolb, Lauren, Skibba, Melissa, Hartmann, Markus, Blöcher, René, Proschak, Ewgenij, Imig, John D.

    Published in Diabetologia (01-10-2018)
    “…Aims/hypothesis The metabolic syndrome is a cluster of risk correlates that can progress to type 2 diabetes. The present study aims to evaluate a novel…”
    Get full text
    Journal Article
  14. 14

    Multitarget molecule, PTUPB, to treat diabetic nephropathy in rats by Khan, Md. Abdul Hye, Hwang, Sung Hee, Barnett, Scott D., Stavniichuk, Anna, Jankiewicz, Wojciech K., Hammock, Bruce D., Imig, John D.

    Published in British journal of pharmacology (01-11-2021)
    “…Background and Purpose Diabetic nephropathy is a common complications related to high morbidity and mortality in type 2 diabetes. We investigated the action of…”
    Get full text
    Journal Article
  15. 15

    The contribution of α1B-adrenoceptor subtype in the renal vasculature of fructose-fed Sprague–Dawley rats by Abdulla, Mohammed H., Sattar, Munavvar A., Abdullah, Nor A., Khan, Md. Abdul Hye, Anand Swarup, Kolla R. L., Johns, Edward J.

    Published in European journal of nutrition (01-06-2011)
    “…Purpose Fructose feeding induces a moderate increase in blood pressure, insulin resistance, and hyperinsulinemia. This study investigated the role of α 1B…”
    Get full text
    Journal Article
  16. 16

    Dual soluble epoxide hydrolase inhibitor - farnesoid X receptor agonist interventional treatment attenuates renal inflammation and fibrosis by Khan, Md Abdul Hye, Nolan, Benjamin, Stavniichuk, Anna, Merk, Daniel, Imig, John D

    Published in Frontiers in immunology (03-01-2024)
    “…Renal fibrosis associated with inflammation is a critical pathophysiological event in chronic kidney disease (CKD). We have developed DM509 which acts…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Kidney-Targeted Epoxyeicosatrienoic Acid Analog, EET-F01, Reduces Inflammation, Oxidative Stress, and Cisplatin-Induced Nephrotoxicity by Imig, John D, Hye Khan, Md Abdul, Burkhan, Anna, Chen, Guan, Adebesin, Adeniyi Michael, Falck, John R

    “…Although epoxyeicosatrienoic acid (EET) analogs have performed well in several acute and chronic kidney disease models, targeted delivery of EET analogs to the…”
    Get full text
    Journal Article
  19. 19

    Dual soluble epoxide hydrolase inhibitor/PPAR-γ agonist attenuates renal fibrosis by Stavniichuk, Anna, Hye Khan, Md. Abdul, Yeboah, Michael M., Chesnik, Marla A., Jankiewicz, Wojciech K., Hartmann, Markus, Blöcher, René, Kircher, Theresa, Savchuk, Olexiy, Proschak, Ewgenij, Imig, John D.

    Published in Prostaglandins & other lipid mediators (01-10-2020)
    “…•Renal fibrosis is the most common pathophysiological event in chronic kidney disease (CKD) and is an independent predictor of long-term CKD prognosis.•A novel…”
    Get full text
    Journal Article
  20. 20

    A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat by Hye Khan, Md. Abdul, Hwang, Sung Hee, Sharma, Amit, Corbett, John A., Hammock, Bruce D., Imig, John D.

    Published in Prostaglandins & other lipid mediators (01-09-2016)
    “…•We investigated effects of a novel dual acting molecule that concurrently inhibits two arachidonic acid metabolizing enzymes (cyclooxygenase-2 and soluble…”
    Get full text
    Journal Article